Sakai R, Inoue D, Ishibashi K, Inoue M, Shirayama T, Yamahara Y, Asayama J, Nakagawa M
Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
J Cardiovasc Pharmacol. 1995 Jun;25(6):953-60. doi: 10.1097/00005344-199506000-00014.
We investigated use-dependent prolongation of interatrial conduction time (IACT) by class I antiarrhythmic drugs in 16 patients. Changes in IACT at the initiation of atrial pacing were used to evaluate the onset kinetics. We examined recovery kinetics by giving a single extra stimulus with a varying coupling interval after discontinuing train stimulation. Time constants of the onset kinetics were 1.52 +/- 0.15/n(fast) and 0.087 +/- 0.031/n(slow) for mexiletine, 0.075 +/- 0.015/n for aprindine, 0.078 +/- 0.019/n for disopyramide, and 0.050 +/- 0.006/n for pilsicainide. The recovery time constants were 203 +/- 66 ms for mexiletine, 1,021 +/- 162 ms for aprindine, 993 +/- 101 ms for disopyramide, and 2,930 +/- 569 ms for pilsicainide. Class I antiarrhythmic drugs produced use-dependent IACT prolongation in humans, with characteristic kinetics for each agent similar to that of depression of the maximum upstroke velocity of cardiac action potential (Vmax) reported in in vitro studies.
我们研究了16例患者中I类抗心律失常药物对心房传导时间(IACT)的使用依赖性延长。心房起搏开始时IACT的变化用于评估起效动力学。我们通过在停止串刺激后给予具有不同耦合间期的单个额外刺激来检查恢复动力学。美西律的起效动力学时间常数分别为1.52±0.15/ n(快)和0.087±0.031/ n(慢),阿普林定的为0.075±0.015/ n,丙吡胺的为0.078±0.019/ n,吡西卡尼的为0.050±0.006/ n。美西律的恢复时间常数为203±66毫秒,阿普林定的为1021±162毫秒,丙吡胺的为993±101毫秒,吡西卡尼的为2930±569毫秒。I类抗心律失常药物在人体中产生了使用依赖性IACT延长,每种药物都有其特征性的动力学,类似于体外研究中报道的心脏动作电位最大上升速度(Vmax)降低的情况。